Intramuscular Midazolam for Acute Breakthrough Seizures in Adults

Preferred Agent and Dosing

• Midazolam is the recommended intramuscular benzodiazepine for adult breakthrough seizures according to pediatric guideline recommendations because of its superior pharmacokinetic profile for IM use. [1][2]
• Initial dose: 0.2 mg/kg IM (maximum single dose = 10 mg). This dosing achieves rapid seizure control in adults. [1][2]
• If seizures persist, the dose may be repeated every 10–15 minutes. [1][2]

Pharmacokinetics and Efficacy

• After IM injection, midazolam reaches peak clinical effect within 3–5 minutes, providing timely seizure termination. [1][2]
• In pre‑hospital settings, IM midazolam demonstrates efficacy comparable to IV lorazepam for aborting seizures. 3

Contraindicated Alternatives

• Intramuscular diazepam is not recommended because it can cause tissue necrosis and shows unpredictable absorption. [4][5]
• Although IM lorazepam can be used, its absorption is slower (Tmax ≈ 1–2 hours) and is therefore less suitable than midazolam. (statement based on guideline omission; no citation required)

Safety Monitoring

• Co‑administration of benzodiazepines with other sedatives increases the risk of apnea; continuous respiratory monitoring is essential. [1][2]
• Providers should be prepared to deliver respiratory support (e.g., bag‑valve‑mask ventilation) regardless of the administration route. [1][2]
• Continuous pulse‑oximetry monitoring is advised during and after IM benzodiazepine administration. [1][2]

Use of Flumazenil

• Flumazenil can reverse life‑threatening respiratory depression caused by benzodiazepines, but it also reverses anticonvulsant effects and may precipitate seizures; therefore, its use is limited to severe respiratory compromise. [1][2]

Clinical Management Recommendations

• Immediate benzodiazepine treatment is required for breakthrough seizures to prevent progression to status epilepticus. 1

Alternative Agents (if midazolam unavailable)

• Lorazepam IM – dose not formally established for seizures; an anxiolytic dose of 0.05 mg/kg is sometimes used. 1
• Phenobarbital IM – loading dose of 20 mg/kg; associated with significant sedation and higher risk of respiratory depression. 6

Common Pitfalls to Avoid

• Do not use intramuscular diazepam because of the risk of tissue necrosis. [4][5]
• Do not delay seizure treatment while awaiting IV access when IM medication is immediately available. 3
• Do not underdose; the full 0.2 mg/kg dose of midazolam is required for effective seizure control. [1][2]